“…In the December 2021 issue of JTCVS Open , Theys and colleagues 4 examined their experience with IE to investigate whether antiplatelet or anticoagulation agents have a protective effect for IE. The study included 2 cohorts: (1) patients who underwent aortic valve replacement with a bioprosthetic valve (AVR cohort) between 2009 through 2019 and (2) patients with IE of the native aortic valve (NVE cohort) between 2007 through 2015.…”